Vera Therapeutics, Inc. (VERA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 0 | -69.99M | -61.91M | -54.8M | -54.41M | -39.18M | -36.88M | -24.78M | -33.83M | -25.14M | -22.97M | -17.77M | -26.29M | -21.16M | -18.42M | -19.03M | -8.98M | -6.44M | -5.48M | -7.67M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 100% | -78.64% | -67.84% | -121.12% | -60.82% | -55.83% | -60.56% | -39.44% | -28.67% | -18.82% | -24.72% | 6.63% | -192.75% | -228.7% | -235.89% | -148.31% | -117.93% | 76.49% | - | - |
| Net Income | -121.03M | -91.1M | -80.29M | -76.53M | -51.69M | -43.42M | -46.63M | -33.71M | -28.38M | -25.66M | -20.1M | -20.16M | -30.07M | -32.44M | -24.68M | -14.85M | -17.09M | -16.85M | -7.61M | -3.44M |
| Depreciation & Amortization | 0 | 135K | 129K | 119K | 85K | 55K | 24K | 15K | 11K | -635K | 6K | 517K | -506K | -597K | -152K | -106K | 9K | 32K | 59K | 50K |
| Stock-Based Compensation | 0 | 10.96M | 9.74M | 9.47M | 7.74M | 6.22M | 5.59M | 4.87M | 4.12M | 0 | 2.92M | 2.68M | 2.67M | 2.75M | 2.45M | 2.02M | 1.66M | 962K | 933K | 713K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 364K | 0 |
| Other Non-Cash Items | 121.03M | -359K | -173K | -1.24M | -1.1M | -1.3M | -1.73M | -2.11M | -963K | 3.22M | -899K | -924K | 580K | 590K | 4.42M | 1.09M | 564K | 5.12M | -125K | -2.57M |
| Working Capital Changes | 0 | 10.36M | 8.69M | 13.38M | -9.44M | -728K | 5.86M | 6.14M | -8.62M | -2.08M | -4.9M | 115K | 1.04M | 8.54M | -465K | -7.19M | 5.87M | 4.29M | 896K | -2.42M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 3.63M | 4.79M | 3.9M | 1.6M | 3.06M | -62K | -545K | -5.91M | -1.18M | -980K | 7.95M | -6.67M | 4.98M | -72K | -244K | 5.94M | 420K | -759K | 1.01M |
| Cash from Investing | 0 | 80.66M | 69.76M | 28.54M | 15.32M | -221.38M | 38.32M | -22.68M | -219.29M | 18.56M | 16.23M | -86.45M | 12.23M | 13.44M | -2.44M | -42.09M | -39.45M | -5M | 0 | 796K |
| Capital Expenditures | 0 | -102K | -133K | -208K | -187K | -645K | -25.11M | -89K | 0 | -63K | 0 | 0 | 0 | 0 | -38K | -6K | -18K | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.4K | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -2.58M | -750K | 0 | 24.87M | 0 | 0 | 0 | 0 | 0 | 12.23K | 0 | -2.4K | 0 | -39.44K | -5M | 0 | 796K |
| Cash from Financing | 0 | 286.28M | 797K | 20.29M | 1.53M | 325.95M | 739K | 3.44M | 276.54M | 24.83M | 297K | 432K | 107.98M | 20.71M | 908K | 48K | 80.27M | 4.92M | 0 | 48.99M |
| Debt Issued (Net) | 0 | 0 | 0 | 19.82M | 0 | 0 | 0 | 0 | 0 | 24.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.92M | 0 | 1K |
| Equity Issued (Net) | 0 | 286.28M | 0 | 464K | 0 | 345M | -13K | 0 | 287.54M | 87K | 0 | 0 | 115M | -1K | 1K | 1K | 86.13M | 0 | 0 | 51.18M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | -13K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 797K | 0 | 1.53M | -19.05M | 752K | 3.44M | -11M | 0 | 297K | 432K | -7.02M | 20.71M | 907K | 47K | -5.86M | 0 | 0 | -2.19M |
| Net Change in Cash | -354.73M | 296.95M | 8.65M | -5.97M | -37.56M | 65.39M | 2.17M | -44.02M | 23.42M | 18.24M | -6.45M | -103.79M | 93.93M | 12.98M | -19.95M | -61.08M | 31.83M | -6.52M | -5.48M | 42.12M |
| Free Cash Flow | 0 | -70.1M | -62.04M | -55.01M | -54.59M | -39.83M | -61.99M | -24.87M | -33.83M | -25.21M | -22.97M | -17.77M | -26.29M | -21.16M | -18.46M | -19.04M | -9M | -6.44M | -5.48M | -7.67M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 100% | -76% | -0.07% | -121.17% | -61.37% | -58% | -169.86% | -39.94% | -28.67% | -19.11% | -24.46% | 6.65% | -192.17% | -228.7% | -236.58% | -148.39% | -118.37% | 76.49% | - | - |
| FCF per Share | - | -1.09 | -0.97 | -0.86 | -0.86 | -0.73 | -1.13 | -0.45 | -0.66 | -0.57 | -0.52 | -0.40 | -0.70 | -0.76 | -0.68 | -0.70 | -0.37 | -0.30 | -0.26 | -0.73 |
| FCF Conversion (FCF/Net Income) | - | 0.77x | 0.77x | 0.72x | 1.05x | 0.90x | 0.79x | 0.74x | 1.19x | 0.98x | 1.14x | 0.88x | 0.87x | 0.65x | 0.75x | 1.28x | 0.53x | 0.38x | 0.72x | 2.23x |
| Interest Paid | 0 | 0 | 1.77M | 0 | 1.58M | 1.66M | 0 | 1.73M | 1.52M | 0 | 863K | -1.62M | 0 | 559K | 0 | 113K | 0 | 17K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |